Rice Hall James & Associates’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.25M Buy
132,063
+2,094
+2% +$74.4K 0.24% 92
2025
Q4
$4.68M Buy
129,969
+120,013
+1,205% +$4.41M 0.26% 87
2025
Q3
$313K Buy
+9,956
New +$357K 0.02% 240

Other funds holding VCEL

Rice Hall James & Associates's VCEL Position: Q1 2026 in Review

Rice Hall James & Associates increased its Vericel Corp (VCEL) stake by 1.6% in Q1 2026, buying an estimated $74.4K and bringing the position to 132,063 shares worth $4.25M. The position accounts for 0.24% of the portfolio, ranked #92.

Rice Hall James & Associates first reported a position in VCEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.68M in Q4 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Rice Hall James & Associates held 132,063 shares of Vericel Corp worth $4.25M as of Q1 2026.
  • Rice Hall James & Associates bought 2,094 Vericel Corp shares in Q1 2026, an estimated $74.4K.
  • Vericel Corp made up 0.24% of Rice Hall James & Associates's portfolio in Q1 2026, its #92 holding.
  • Rice Hall James & Associates first reported a position in Vericel Corp in Q3 2025 and has held it in 3 quarters since.
  • Rice Hall James & Associates's Vericel Corp position peaked at $4.68M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.